Stakeholders Management Assessment Answer

Introduction

During the course of the global pandemic several nations around the world has been hit hard, India is no exception in that context. However, for the sake of safeguarding its massive population, the incumbent regime has devised approaches through which vaccines which are developed can be readily available to the public. One of the interesting aspects that should be taken into consideration in this particular context is that despite this rigorous effort of the government, numerous people across India remain hesitant regarding getting vaccinated in the first place (Lazarus et al. 2020). There are a number of reasons which can be pointed out as to why they are hesitant. However, the most notable one is the rigorous spread of misinformation along with conspiracy theory regarding the efficacy as well as the safety of these vaccines. Aside from that people are also skeptical regarding the speed at which the vaccines were developed, owing to the fact that developing a vaccine within such short span of time, without appropriate testing would not be adequate (Chandani et al. 2020). Moreover, lack of proper trust in the incumbent regime along with inadequate healthcare system, particularly in the marginalized community it has also played a significant role in Indian populace not accepting the vaccination. The ramifications of vaccine hesitancy with respect to Indian corporations and businesses are profound. With a considerable segment of the populace remaining unvaccinated, there persists a looming threat of COVID-19 outbreaks and resulting disruptions in business operations (Jain et al. 2021). Additionally, the economic revival of the nation is inextricably linked to the success of the vaccination drive. The protraction of vaccine hesitancy could impede the resumption of normalcy, thereby aggravating the economic repercussions of the pandemic. In light of the challenge posed by the COVID-19 pandemic, Indian corporations and businesses have assumed an active stance in promoting vaccination and countering misinformation. This comprises measures to enlighten their workforce and localities on the significance of vaccination, alongside providing incentives and resources to bolster vaccination drives (Danabal et al. 2021). In sum, the mitigation of vaccine hesitancy assumes paramount importance for safeguarding the health and welfare of the Indian populace and advancing the prosperity of the nation's enterprises and economy.

A Brief Overview of the Concern Among the Indian Populace Regarding Vaccines

Concerns among Indian populace regarding vaccines oriented to resolve COVID-19 are multifaceted in nature, since it varies from one person to another. After meticulously analyzing the concern, an inference can be drawn that the most common concern among the populace is that the potential side effects associated with these vaccines are deterring individuals to accept it.To put it in simple perspective, the adverse reaction pertinent with vaccines is specifically hindering the Indian government’s approach of ensuring that mass is vaccinated (Achrekar et al. 2022). Another important concern is the efficacy associated with the vaccines, while certain individuals are quite confident that it is not feasible for any organization throughout the globe to prepare a vaccine in such short notice, while the others are largely relying on diverse misinformation that the significance of vaccine would necessarily deteriorate. In view of the fact that these vaccines are not going to safeguard them from the new variants of the virus. As a consequence of which several individuals have questioned the efficacy of these vaccines to the ruling regime. Aside from that the general distrust of vaccine along with poor quality of health care facilities have also deter massive segment of Indian population to align themselves with the notion of vaccination campaign driven by Indian government through social media platforms and other forms of mass communication channels (Lazarus et al. 2020). An additional apprehension pertains to the perceived hastened development and authorization of the vaccines. A considerable number of individuals hold the view that the vaccines did not undergo sufficient testing before their public release, thereby casting doubt on their safety and efficacy. Furthermore, there is a prevailing concern about the accessibility and availability of the vaccines, particularly in remote and disadvantaged communities. Some individuals worry that impediments such as cost, inadequate transportation, or limited vaccine stocks may preclude them from obtaining the vaccine.

The Stakeholder’s Mapping

The conundrum of vaccine hesitancy in India encompasses a diverse group of stakeholders who are accountable for mitigating the apprehensions and augmenting the acceptance of COVID-19 vaccines. These stakeholders comprise the government, which is entrusted with devising policies and initiatives that bolster vaccine acceptance and assuage vaccine hesitancy. This encompasses ensuring equitable dissemination of vaccines, imparting precise information regarding their safety and efficacy, and addressing apprehensions regarding the expedited development and approval process. Aside from that various stakeholders have a pivotal role to play in addressing concerns surrounding the COVID-19 vaccines, including their perceived rushed development and approval, accessibility and availability, and vaccine hesitancy in India. Healthcare providers, for instance, are vital in educating patients about the vaccines' benefits and assuaging their concerns by providing accurate information and dispelling misconceptions. Civil society organizations, on the other hand, can develop targeted messaging and outreach campaigns to reach marginalized communities, while advocating for equitable access to vaccines (Chandani et al. 2020). Private sector entities such as corporations and businesses can also support vaccination efforts by providing resources and incentives to their employees and communities, thereby promoting accurate vaccine information and dispelling misinformation.

Design Thinking Tool

After intricately analyzing the context of this study it can be inferred that a design thinking tool that is applicable in this particular instance is ‘empathy interview’. The concerns of the stakeholder can be analyzed intricately so that a deeper understanding of the issues as to what is impeding the mass from getting vaccinated can be evaluated. Aside from that, pain points and motivators regarding the issue can also be identified so that the root cause of the concern can be traced. This is necessary in view of developing a solution that not only addresses the stakeholder’s needs, but at the same time resolves this conundrum once and for all. During the course of empathy interview, open-ended questionnaires are going to be asked to willing participants regarding their perspective and experiences, which would later on be analyzed for meticulous interpretation. These insights can later on be subjected to intricate assessment so that a more effective communication as well as engagement strategies can be augmented, based on which design of solutions that are oriented to resolve the stakeholders concern can be conducted successfully.

Plan for Interview

The first course of action that is required in this particular instance is to define the objective or the purpose of the interview, so that the participants are well debriefed regarding the reason as to why this interview is taking place. Followed by selecting the participant and developing open-ended questionnaires, that would encourage the participant to share their respective emotions and experiences associated with the overall vaccination process (Achrekar et al. 2022). In order to ensure that the participant is quite comfortable during the interview, the interviewer should debrief the safety protocols that are incorporated in terms of safeguarding the credentials of the participant. Finally, actively listening to the responses of the respondent and asking follow-up questions to gain deeper insight regarding the issue should be emphasized upon. The entire interview should be recorded so that it can later be analyzed and interpreted accordingly.

Empathy Interview

1. What concerns do you have about getting vaccinated for COVID-19?

The main concern that I have is that the efficacy of the vaccine is not as what it is promoted, since the variants of this virus would keep on evolving. Hence, vaccinations would not be the permanent solution.

2. How did you first hear about the vaccine?

I first learned about the vaccinations and their adversarial effect in the social media platforms. On top of that I also keep a keen watch on the news media and other forms of mass media through which I can accumulate information pertinent with vaccinations (Shaheed et al. 2022).

3. Have you talked to anyone about the vaccine? What did they say?

As of now I haven't talked to anyone who has the authority over this topic. However, as far as my colleagues are concerned along with my neighbors, the majority of them have already experienced adversarial effects after being vaccinated. I have literally seen individuals who are quite well. However, after getting the shot, they suddenly experienced high fever. This has inherently incorporated a notion of fear and as well as anxiety in my mind regarding the efficacy of the vaccinations.

4. Have you experienced any adverse reactions to vaccines in the past?

Previously, I had no adversarial reactions to vaccines. I've already taken two to three vaccines. However, those vaccines are created over the course of a longer time frame, unlike this one, which was developed in short notice. This is not actually feasible for a government or any organization to come up with vaccines at such lightning speed, just like the organizations which are providing vaccines across India had done. Apparently, it would seem to be quite exemplary in nature. However, in reality, if empirical analysis of the efficacy as well as the adversarial effects of the vaccines is carried out, then the feasibility of these vaccines in real life instances can only be evaluated.

5. What do you know about the safety and efficacy of the COVID-19 vaccine?

I literally want to know what kind of adversarial effects this vaccine is capable of inculcating amidst human beings, because it is derived from ape genes in South America.

6. Are there any factors that are preventing you from getting vaccinated?

As I've mentioned before that I'm quite nervous as well as uncertain whether I would get vaccinated because of their aforementioned reasons.

7. How do you feel about the idea of getting vaccinated?

I have literally nothing against the idea of vaccination as long as I'm quite confident regarding the inculcation of components that are going to be incorporated in my body through vaccines. As of this instance, I'm quite uncertain as well as not well versed regarding the essential components that they're using in terms of developing the vaccines. As a result of which I'm not confident or supporting the idea of getting vaccinated (Shaheed et al. 2022).

8. What kind of information or support would make you more comfortable getting vaccinated?

Information pertaining to essential components which are used to develop the vaccine would definitely help me to be more aligned with being vaccinated.

9. How do you think the vaccine will impact your daily life?

I have seen many colleagues who are quite healthy to experience adversarial effect which has proven to be quite detrimental for their health after being vaccinated. Hence, it is fair to state that I think that this vaccine will definitely impact in a negative manner in my day-to-day life and would impede me to act accordingly (Sahoo and Ashwani, 2020).

10. Are there any specific concerns you have about the vaccine rollout in India?

The rollouts are quite seamless as well as swift in nature; I do not have any specific concern against the rollout or reservation for that matter. The only reservation I have is that why is the government not disclosing the essential adversarial effects that are associated with the vaccines and why the organizations which are entrusted with the responsibility of developing the vaccines in the first place, are not removing the traces of those elements through which the adversarial effects are taking place (Das et al. 2020).

Notes or Insights from the Interviews

The individual's reluctance to receive the COVID-19 vaccine appears to stem from apprehensions surrounding its efficacy and safety. Their sources of information include social and news media platforms, as well as accounts from acquaintances who allegedly experienced adverse reactions subsequent to vaccination. Of particular concern is the vaccine's ability to combat emerging viral strains, in addition to doubts regarding the inclusion of ape genes in its development. The individual in question harbours reservations regarding the COVID-19 vaccine, largely influenced by concerns surrounding its efficacy and safety, shaped by data from a myriad of sources, including social and news media, as well as personal anecdotes from acquaintances. Although having had no prior adverse experiences with vaccines, the individual remains uncertain of the COVID-19 vaccine's feasibility, developed as it was within a relatively short period (Dev and Sengupta, 2020). The individual maintains that only empirical analysis can determine the vaccine's practicality in real-world situations. Furthermore, the individual posits that having a deeper understanding of the vaccine's essential components would assuage their fears. Of particular concern to the individual are the vaccine's potential adverse effects on their daily life and its ability to protect against emerging viral strains. While the individual does not hold any specific reservations regarding the vaccine's rollout in India, they remain apprehensive about the lack of disclosure regarding potential adverse effects associated with the vaccine (Barbate et al. 2021).

Empathy Mapping

Persona: A 35-year-old working mother with two young children living in a rural area of India

Gathered Information:

• Says: "I'm worried about the safety of the vaccine. I've heard stories about people getting sick after getting vaccinated."
• Thinks: "I don't know if the vaccine will actually work, especially with new variants of the virus emerging."
• Feels: Anxious and uncertain about the vaccine, but also concerned about protecting her family from COVID-19 (Agrawal et al. 2020).
• Does: Has been reading news articles and social media posts about the vaccine, but hasn't yet scheduled an appointment to get vaccinated.

Empathy Map Table

The 5Y problem-solving model

The 5Y problem-solving model is an approach that is primarily utilized to determine the root cause associated with the problem by consecutively asking "Why?" This model is applicable to determine as to why people in India are hesitant to get vaccinated:

Y1) Why are people hesitant to get vaccinated in India?

In view of the fact that they are anxious regarding their own safety of the vaccine.

Y2) Why are they worried about the safety of the vaccine?

Due to the fact that there have been massive reports of adverse reactions coupled with side effects (Joshi et al. 2020).

Y3) Why have there been reports of adverse reactions and side effects?

Owing to the fact that the vaccines were developed and approved within an accelerated timeline due to the sheer urgency of the pandemic.

Y4) Why were the vaccines developed and approved on an accelerated timeline?

For the reason that there was a global public health crisis and the vaccines were seen as a crucial tool to control the spread of the virus.

Y5) Why was there a global public health crisis?

It occurred due to the drastic spread of the COVID-19 virus and the lack of preparedness and response systems in place to deal with the pandemic.

On the basis of the aforementioned discussion, it can be inferred that the rudimentary reason as to why the problem occurred in the first place regarding vaccination is that response system as well as the preparedness in order to deal with pandemic driven panic is not readily available at the government's disposal, which in turn accelerated the feasibility of spreading misinformation among the general population. Coupled with reports of adversarial reaction and harmful side effects, massive number of people refrained from being vaccinated in the first place (Sidhu et al. 2020). In order to resolve this menace, it is quintessential to concentrate upon augmenting preparedness as well as responsive system associated with tackling such circumstances in the near future. On top of that enhancing transparency and streamlining channels of communication regarding efficacy as well as safety of the vaccines should also be emphasized.

Journey map

The trajectory of an individual's decision-making process concerning the COVID-19 vaccine commences with the acquisition of knowledge regarding the vaccine through social and mass media outlets. These sources of information initially instil a sense of doubt in the individual's mind concerning the vaccine's efficacy. Subsequently, apprehension and disquietude arise when the individual becomes privy to accounts of unfavourable outcomes experienced by peers and acquaintances, resulting in a state of indecisiveness regarding vaccine administration (Gupta et al. 2020). The individual embarks on an initial journey of vaccine hesitancy, triggered by information disseminated through social and mass media regarding the COVID-19 vaccine's safety and effectiveness. Subsequently, the individual experiences an increasing sense of fear and anxiety upon learning about adverse effects encountered by acquaintances, leading to a state of indecision regarding the vaccination (Surana et al. 2020). The individual seeks out further information and support to alleviate their concerns, yet remains sceptical due to the negative impact allegedly observed in the lives of peers and colleagues.

Final Problem Definition

The issue at hand pertains to the uncertainty, trepidation, and skepticism that pervade an individual's mind concerning the safety and effectiveness of the COVID-19 vaccine. This is primarily due to the unfavorable experiences encountered by colleagues and acquaintances post-vaccination, which engenders fear and anxiety (Uppal et al. 2021). To alleviate this skepticism, the individual seeks additional information and support, albeit to no avail, owing to the persisting negative impact that allegedly besets their social circle. Consequently, the dearth of transparency and inadequate disclosure of adverse effects by the vaccine development agencies and government authorities exacerbates the situation, necessitating the need for clear and unambiguous communication to allay public concerns and ensure a smooth vaccine rollout (Kusi-Sarpong et al. 2019).

HMW exercise

• HMW develop a more accessible and intelligible information regarding the safety and efficacy of COVID-19 vaccines to eradicate vaccination hesitancy?
• HMW augment a community-driven campaign that effectively impart knowledge amidst people about the benefits of COVID-19 vaccination and mitigates their fears and concerns?
• HMW incentivize individuals who are hesitant about COVID-19 vaccination to get vaccinated without impinging on their autonomy or personal beliefs?
• HMW make certain that individuals with limited access to healthcare, resources, or transportation can get vaccinated to reduce vaccination hesitancy?
• HMW work with healthcare providers to resolve and combat misinformation and conspiracy theories about COVID-19 vaccines that contribute to vaccination hesitancy?

Project’s scope

The purpose of this project is to devise a solution that effectively tackles vaccine hesitancy by comprehensively understanding the apprehensions and motivations of individuals who exhibit reluctance in receiving the COVID-19 vaccine (Ganguly et al. 2019). This will entail conducting empathy interviews, diligently analyzing the amassed data, and formulating informed recommendations for healthcare organizations and policymakers to augment vaccine acceptance. The ultimate objective of this project is to advance public health by effectively addressing vaccine hesitancy and subsequently increasing the vaccination rates.

Reflection

References

Achrekar, G.C., Batra, K., Urankar, Y., Batra, R., Iqbal, N., Choudhury, S.A., Hooda, D., Khan, R., Arora, S., Singh, A. and Chirico, F., 2022. Assessing COVID-19 booster hesitancy and its correlates: An early evidence from India. Vaccines, 10(7), p.1048.

Agrawal, S., Jamwal, A. and Gupta, S., 2020. Effect of COVID-19 on the Indian economy and supply chain.

Barbate, V., Gade, R.N. and Raibagkar, S.S., 2021. COVID-19 and its impact on the Indian economy. Vision, 25(1), pp.23-35.

Centobelli, P., Cerchione, R. and Singh, R., 2019. The impact of leanness and innovativeness on environmental and financial performance: Insights from Indian SMEs. International Journal of Production Economics, 212, pp.111-124.

Chandani, S., Jani, D., Sahu, P.K., Kataria, U., Suryawanshi, S., Khubchandani, J., Thorat, S., Chitlange, S. and Sharma, D., 2021. COVID-19 vaccination hesitancy in India: State of the nation and priorities for research. Brain, behavior, & immunity-health, 18, p.100375.

Danabal, K.G.M., Magesh, S.S., Saravanan, S. and Gopichandran, V., 2021. Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India–a community based survey. BMC Health Services Research, 21(1), pp.1-10.

Das, D., Kumar, K. and Patnaik, S., 2020. The impact of Covid-19 in Indian economy–an empirical study. International Journal of Electrical Engineering and Technology, 11(3).

Dev, S.M. and Sengupta, R., 2020. Covid-19: Impact on the Indian economy. Indira Gandhi Institute of Development Research, Mumbai April.

Ganguly, A., Talukdar, A. and Chatterjee, D., 2019. Evaluating the role of social capital, tacit knowledge sharing, knowledge quality and reciprocity in determining innovation capability of an organization. Journal of knowledge management.

Gupta, H., Kusi-Sarpong, S. and Rezaei, J., 2020. Barriers and overcoming strategies to supply chain sustainability innovation. Resources, Conservation and Recycling, 161, p.104819.

Gupta, G.K. and Shukla, P., 2020. Insights into the resources generation from pulp and paper industry wastes: challenges, perspectives and innovations. Bioresource technology, 297, p.122496.

Hossain, M., 2020. Frugal innovation: Conception, development, diffusion, and outcome. Journal of Cleaner Production, 262, p.121456.

Irfan, M., Zhao, Z.Y., Ahmad, M. and Mukeshimana, M.C., 2019. Critical factors influencing wind power industry: A diamond model based study of India. Energy Reports, 5, pp.1222-1235.

Jain, J., Saurabh, S., Goel, A.D., Gupta, M.K., Bhardwaj, P. and Raghav, P.R., 2021. COVID-19 vaccine hesitancy among undergraduate medical students: results from a nationwide survey in India. MedRxiv, pp.2021-03.

Joshi, A., Bhaskar, P. and Gupta, P.K., 2020. Indian economy amid COVID-19 lockdown: A prespective. J. Pure Appl. Microbiol, 14, pp.957-961.

Kusi-Sarpong, S., Gupta, H. and Sarkis, J., 2019. A supply chain sustainability innovation framework and evaluation methodology. International Journal of Production Research, 57(7), pp.1990-2008.

Lazarus, J.V., Wyka, K., Rauh, L., Rabin, K., Ratzan, S., Gostin, L.O., Larson, H.J. and El-Mohandes, A., 2020. Hesitant or not? The association of age, gender, and education with potential acceptance of a COVID-19 vaccine: a country-level analysis. Journal of Health Communication, 25(10), pp.799-807.

Sahoo, P. and Ashwani, 2020. COVID-19 and Indian economy: Impact on growth, manufacturing, trade and MSME sector. Global Business Review, 21(5), pp.1159-1183.

Shaheed, R., Acharya, S., Shukla, S., Kesarwani, M. and Acharya, N., 2022. Psychological aspects of COVID-19 vaccine in Indian population. Are we still hesitant?. Journal of Family Medicine and Primary Care, 11(8), pp.4280-4285.

Sidhu, G.S., Rai, J.S., Khaira, K.S. and Kaur, S., 2020. The Impact of COVID-19 pandemic on different sectors of the Indian Economy: A descriptive study. International Journal of Economics and Financial Issues, 10(5), pp.113-120.

Surana, K., Singh, A. and Sagar, A.D., 2020. Strengthening science, technology, and innovation-based incubators to help achieve Sustainable Development Goals: Lessons from India. Technological Forecasting and Social Change, 157, p.120057.

Uppal, A., Chakrabarti, R., Chirmule, N., Rathore, A. and Atouf, F., 2021. Biopharmaceutical industry capability building in India: report from a symposium. Journal of Pharmaceutical Innovation, pp.1-8.     

You Might Also Like:-

Management Assignment Sample

What are the Four Steps of Effective Process Mapping?

BUS300: Evaluating Innovation and Entrepreneurship Concentration in Developed Nations Assessment Answer

Looking For Complete Assignment Sample Get It On WhatsApp